skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > ganglioside gq1(4-) > alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)-beta-gal-(1->3)-beta-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-gal-(1->4)-beta-glc-(1<->1')-cer(4-) > n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)

اصطلاح مرجح

n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d20:0)(5-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • -4

فرمول

  • C91H149N6O55R

جرم

  • 2207.168

جرم تک‌ایزوتوپی

  • 2205.90468

اسمایلٓ

  • [C@@]1(O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H](OC[C@@H]([C@@H](CCCCCCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]3O)O)CO)CO)O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)O[C@H]5[C@@H]([C@@H](O[C@]6(O[C@]([C@@H]([C@H](C6)O)NC(C)=O)([C@@H]([C@H](O[C@]7(O[C@]([C@@H]([C@H](C7)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C(=O)[O-])CO)O)[H])C([O-])=O)[C@H]([C@H](O5)CO)O)O)NC(C)=O)(O[C@]([C@H](NC(=O)C)[C@H](C1)O)([C@@H]([C@H](O[C@]8(O[C@]([C@@H]([C@H](C8)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)CO)O)[H])C([O-])=O

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141709

این مفهوم را بارگیری کن: